Suchergebnisse - "Park, Sojung"

PubPharm (8)

1

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

enthalten in: BMC cancer | 2021

von Park, S. | Lee, S. | Kim, D. | +7

2

Clinical significance of EGFR mutation types in lung adenocarcinoma : A multi-centre Korean study

enthalten in: PloS one | 2020

von Yoon, H. | Ryu, J. | Sim, Y. | +7

3

Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer

enthalten in: Tumori | 2019

von Kwon, B. | Park, J. | Kim, S. | +6

4

Non-Small Cell Lung Cancer with Resistance to EGFR-TKI Therapy : CT Characteristics of T790M Mutation-positive Cancer

enthalten in: Radiology | 2018

von Koo, H. | Kim, M. | Park, S. | +6

CommentIn: J Thorac Dis. 2018 Nov;10(Suppl 33):S4113-S4116. - PMID 30631569

5

Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid

enthalten in: Clinical chemistry and laboratory medicine | 2017

von Park, S. | Hur, J. | Lee, K. | +4

6

Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed

enthalten in: BMC cancer | 2016

von Park, S. | Kim, H. | Choi, C. | +7

7

Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

enthalten in: Oncotarget | 2016

von Park, J. | Choi, Y. | Kim, S. | +9

8

Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements

enthalten in: Clinical lung cancer | 2015

von Park, S. | Park, T. | Choi, C. | +6

1
[1]